Stout is pleased to announce that its client, MediGroup (“MG”), has sold a significant stake to a fund managed by DECALIA Capital. Stout served as exclusive financial advisor to MG in connection with this transaction.

MG was founded in 2015 by seasoned doctors in the French-speaking part of Switzerland. The company operates three radiology centers and treats more than 7,000 patients per year.

MG’s medical network offers regional doctors and patients high-quality care and a broad range of specialties delivered with state-of-the-art equipment. Operated by a team of best-in-class specialists, MG will pursue its development both organically and through acquisitions.

“The final result exceeded all our expectations,” said MG’s founders. “The Stout team was very supportive and coordinated the whole process with our best interests in mind. As initiators of the project, the founders will continue leading the company, strengthened by additional financial resources.”

Christophe Lapaque, Managing Director and Head of Stout’s Lausanne, Switzerland, office, led the Stout deal team. “We are proud of having been able to collaborate with great entrepreneurs and accompany MediGroup during the whole sale process, leading to the successful outcome,” said Christophe.

See more information on our Investment Banking services.